Adial Pharmaceuticals (NASDAQ: ADIL) company logo — Pharmaceutical Manufacturing
Adial Pharmaceuticals (NASDAQ: ADIL) Email Format

Adial Pharmaceuticals (NASDAQ: ADIL)

Pharmaceutical Manufacturing
Glen Allen, Virginia

About Adial Pharmaceuticals (NASDAQ: ADIL)

Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions. The Company’s lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) and is currently being investigated in the Company’s landmark ONWARD Phase 3 clinical trial for the potential treatment of AUD in subjects with certain target genotypes, which are to be identified using the Company’s proprietary companion diagnostic genetic test. A Phase 2b clinical trial of AD04 for the treatment of AUD showed promising results in reducing frequency of drinking, quantity of drinking and heavy drinking (all with statistical significance), and no overt safety concerns (there were no statistically significant serious adverse events reported). AD04 is also believed to have the potential to treat other addictive disorders such as Opioid Use Disorder, gambling, and obesity. The Company is also developing adenosine analogs for the treatment of pain and other disorders.

Find Adial Pharmaceuticals (NASDAQ: ADIL) Execs' Valid Emails

Get verified emails and mobile numbers for people at this company. You only pay for what we find.

Company Details

Annual Revenue
0-500K
Industry
Pharmaceutical Manufacturing
Size
11-50 employees
Type
Public Company
Location
Glen Allen, Virginia
Country
United States

Frequently Asked Questions about

Adial Pharmaceuticals (NASDAQ: ADIL) operates in the Pharmaceutical Manufacturing industry and is headquartered in United States.

Adial Pharmaceuticals (NASDAQ: ADIL) has approximately 11-50 employees employees.

Adial Pharmaceuticals (NASDAQ: ADIL) is based in Glen Allen, Virginia, United States.

Yes. Adial Pharmaceuticals (NASDAQ: ADIL) is a publicly traded company.

You can reach Adial Pharmaceuticals (NASDAQ: ADIL)’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.

Find verified emails and phone numbers for professionals like those at

Every email is verified before it is returned and labelled Valid or Risky.

Find verified emails at this company

An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.

Scalelist - Agent Storefront, powered by ZeroClick